Editas Medicine, Inc.
EDIT
$2.65
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 56.63% | 32.49% | 5.10% | -22.44% | -51.22% |
| Total Depreciation and Amortization | -39.16% | -9.16% | 86.23% | 15.87% | 6.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.14% | 18.35% | 31.59% | 53.57% | 19.92% |
| Change in Net Operating Assets | -411.66% | -1,005.19% | -235.57% | -31.88% | 621.15% |
| Cash from Operations | 32.52% | 21.42% | 1.18% | -22.31% | -42.34% |
| Capital Expenditure | 91.72% | 93.12% | 88.67% | 48.27% | -48.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -64.18% | -18.70% | -16.26% | 1,437.47% | 953.36% |
| Cash from Investing | -63.12% | -14.48% | -12.61% | 2,859.94% | 803.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,968.46% | 5,435.38% | 2,456.91% | 786.77% | -98.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -105.20% | -- | -- | -- |
| Cash from Financing | -22.96% | -27.77% | 7,551.46% | 5,881.32% | -53.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.39% | 76.16% | 416.09% | 147.39% | 216.17% |